Carteolol FDA Link Generic

A beta-adrenergic antagonist used as an anti-arrhythmia agent, an anti-angina agent, an antihypertensive agent, and an antiglaucoma agent.

Also Known As:

Carteolol Hydrochloride; Carteolol Monohydrochloride; OPC-1085; Hydrochloride, Carteolol; Monohydrochloride, Carteolol; OPC 1085; OPC1085; 2(1H)-Quinolinone, 5- (3- ((1,1- dimethylethyl)amino)- 2- hydroxypropoxy)- 3,4- dihydro-

Pharmalogical Action Categories:

Adrenergic beta-Antagonists
Anti-Arrhythmia Agents
Antihypertensive Agents
Sympatholytics

Organic Chemicals: 140
- Amines: 4925
  - Amino Alcohols: 20
    - Propanolamines: 4
      - Phenoxypropanolamines: 1
        Carteolol: 160
- Alcohols: 610
  - Amino Alcohols: 20
    - Propanolamines: 4
      - Phenoxypropanolamines: 1
        Carteolol: 160
  - Propanols: 3
    - Propanolamines: 4
      - Phenoxypropanolamines: 1
        Carteolol: 160
Heterocyclic Compounds: 207
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Quinolines: 148
      - Quinolones: 2966
        Carteolol: 160

M Lablache Combier Selected Research

M Lablache Combier Research Topics

Disease

Drug/Important Bio-Agent (IBA)